TITLE

Pharmacological challenge with a serotonin 1D agonist in alcohol dependence

PUB. DATE
January 2005
SOURCE
BMC Psychiatry;2005, Vol. 5, p31
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
43698861

 

Related Articles

  • Prozac may help depressed alcoholics.  // Addiction Letter;Mar1994, Vol. 10 Issue 3, p7 

    Highlights findings from `Fluoxetine Trial in Suicidal Depressed Alcoholics,' by Jack R. Cornelius, et al in the `Pharmacology Bulletin.' Potential of Prozac for the treatment of depressed alcoholics; Study methods; Selective serotonin agonists.

  • Agents in Development for Anxiety Disorders: Current Status and Future Potential. Hood, S.D.; Argyropoulos, S.V.; Nutt, D.J. // CNS Drugs;2000, Vol. 13 Issue 6, p421 

    Benzodiazepines have been used as anxiolytics for many years, despite well described withdrawal effects and drug interactions. Serotonergic antidepressants, which benefit from a favourable adverse effect profile and do not cause dependence, are now established first-line treatments for anxiety...

  • Anxiety and Alcoholism: A Serotonin Link. Tollefson, Gary D. // British Journal of Psychiatry;Sep91 Supplement, Vol. 159, p34 

    The augmentation of serotonin (5-HT) neurotransmission attenuates alcohol consumption, whereas depletion enhances use. A number of serotonin-specific pharmacological probes appear to be effective in reducing the voluntary consumption of alcohol. The 5-HT1A receptor agonist buspirone is an...

  • The Opioidergic-Alcohol Link: Implications for Treatment. Modesto-Lowe, Vania; Fritz, Eleanor M. // CNS Drugs;2005, Vol. 19 Issue 8, p693 

    Preclinical and clinical data implicate the endogenous opioid system in alcohol dependence. In vitro studies show that rodent pituitary and hypothalamic tissue responds to acute exposure to alcohol by releasing β-endorphins. In vivo studies suggest differential activity of endogenous opioid...

  • Asperger BozukluÄŸu Olan Bir Ergende Aripiprazol Aripiprazole in an Adolescent with Asperger's Disorder. ALPASLAN, Ahmet Hamdi; SOYLU, Nusret; GÜZEL, Halil İbrahim // Yeni Symposium;May2013, Vol. 51 Issue 2, p80 

    Pervasive developmental disorder (PDD) is a challenging psychiatric condition characterized by impairment in social interactions, deficits in communication and challenges with stereotypic behaviors. Children with PDD often display severe maladaptive behaviors, including aggression,...

  • Effects of short-term administration of valproate on serotonin-1A and dopamine receptor function in healthy human subjects. Delva, Nicholas J.; Brooks, Deborah L.; Franklin, Michael; Al-Said, Khalid; Hawken, Emily R.; Merali, Zul; Lawson, J. Stuart; Ravindran, Arun V. // Journal of Psychiatry & Neuroscience;Nov2002, Vol. 27 Issue 6, p429 

    Objective: To examine the effects of short-term valproate treatment on human brain serotonin and dopamine function by means of challenge tests with ipsapirone, a partial agonist at 5-HT[sub IA] receptors, and apomorphine, a dopamine receptor agonist. Design: Experimental challenge-rechallenge,...

  • Agonistic and Antagonistic Bivalent Ligands for Serotonin and Dopamine Receptors Including their Transporters. Decker, Michael; Lehmann, Jochen // Current Topics in Medicinal Chemistry;Feb2007, Vol. 7 Issue 4, p347 

    This review deals with the literature (1982-2006) concerning bivalent ligands for dopamine (D) and serotonin (5-HT) receptors, as well as for their respective transporters. The design, synthesis, and pharmacological evaluation of bivalent agonists and antagonists for dopamine and serotonin...

  • Metabolic disease: New opportunity for serotonin receptor agonists. Crunkhorn, Sarah // Nature Reviews Drug Discovery;Jan2008, Vol. 7 Issue 1, p17 

    The article discusses a research on serotonin receptor agonists. This paper focuses on new treatments in diabetes as the number of patients with type 2 diabetes is increasing. Pharmacological modulation on serotonin receptor agonists improving glucose tolerance and plasma reduction in insulin...

  • A Systemically Administered Neurotensin Agonist Blocks Disruption of Prepulse Inhibition Produced by a Serotonin-2A Agonist. Feifel, David; Melendez, Gilia; Shilling, Paul D. // Neuropsychopharmacology;Apr2003, Vol. 28 Issue 4, p651 

    Prepulse inhibition (PPI) of the startle reflex can be disrupted by drugs that act as agonists at the serotonin (5-HT) 2A receptor, such as DOI, and this effect is blocked by drugs that inhibit 5-HT2A transmission. We tested the effects of systemic administration of PD149163, a neurotensin...

  • Occupancy of dopamine D and D and serotonin 5-HT receptors by the novel antipsychotic drug candidate, cariprazine (RGH-188), in monkey brain measured using positron emission tomography. Seneca, Nicholas; Finnema, Sjoerd; Laszlovszky, István; Kiss, Béla; Horváth, Attila; Pásztor, Gabriella; Kapás, Margó; Gyertyán, István; Farkas, Sándor; Innis, Robert; Halldin, Christer; Gulyás, Balázs // Psychopharmacology;Dec2011, Vol. 218 Issue 3, p579 

    Rationale: Cariprazine is a novel antipsychotic drug candidate that exhibits high selectivity and affinity to dopamine D and D receptors and moderate affinity to serotonin 5-HT receptors. Targeting receptors other than D may provide a therapeutic benefit for both positive and negative symptoms...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics